Investigating modifications to participant information materials to improve recruitment into a large randomized trial.

Investigating modifications to participant information materials to improve recruitment into a large randomized trial.

<p><strong>Background:</strong> Large randomized trials are the best method to test the efficacy and safety of treatments expected to have moderate effects. We observed a significant decline in potential participants’ response to mailed invitations to participate...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	HPS2-THRIVE Collaborative Group, Haynes, R, Chen, F, Wincott, E, Dayanandan, R, Lay, MJ, Parish, S, Bowman, L, Landray, MJ, Armitage, J
Format:	Journal article
Język:	English
Wydane:	BioMed Central 2019

Podobne zapisy

Investigating modifications to participant information materials to improve recruitment into a large randomized trial
od: The HPS2-THRIVE Collaborative Group, i wsp.
Wydane: (2019-12-01)

Serious adverse effects of extended-release niacin/laropiprant: results from the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial
od: Haynes, R, i wsp.
Wydane: (2019)

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.
od: HPS2-THRIVE Collaborative Group, i wsp.
Wydane: (2013)

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)—A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics
od: Landray, M, i wsp.
Wydane: (2017)

Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
od: Aung, T, i wsp.
Wydane: (2016)

Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials
od: Offer, A, i wsp.
Wydane: (2019)

Recruiting patients cost-effectively by mail.
od: Aung, T, i wsp.
Wydane: (2011)

Comparison of the accuracy and completeness of records of serious vascular events in routinely collected data vs clinical trial–adjudicated direct follow-up data in the UK: secondary analysis of the ascend randomized clinical trial
od: Harper, C, i wsp.
Wydane: (2021)

Accelerating clinical trials: time to turn words into action
od: Landray, MJ, i wsp.
Wydane: (2023)

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
od: Hopewell, JC, i wsp.
Wydane: (2020)

Cardiovascular outcomes among participants with diabetes in the recent large statin trials.
od: Armitage, J, i wsp.
Wydane: (2004)

Niacin for reduction of cardiovascular risk.
od: Landray, M, i wsp.
Wydane: (2014)

Niacin for reduction of cardiovascular risk.
od: Landray, M, i wsp.
Wydane: (2014)

Comparison of routinely collected data with clinical trial adjudicated direct follow-up: post-hoc analyses of serious cardiovascular events from the United Kingdom-based ASCEND randomized trial
od: Harper, C, i wsp.
Wydane: (2021)

Design, recruitment, and baseline characteristics of the LENS trial
od: The LENS Collaborative Group
Wydane: (2024)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
od: Emberson, JR, i wsp.
Wydane: (2007)

Reliability of major bleeding events in UK routine data vs clinical trial adjudicated follow-up data
od: Harper, C, i wsp.
Wydane: (2023)

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
od: Bowman, L, i wsp.
Wydane: (2017)

The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
od: Kent, S, i wsp.
Wydane: (2016)

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
od: Mafham, MM, i wsp.
Wydane: (2019)

Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors.
od: Bowman, L, i wsp.
Wydane: (2007)

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.
od: Hopewell, J, i wsp.
Wydane: (2011)

Genetic variation in lipid response to statin therapy in 18,705 participants in the heart protection study
od: Hopewell, J, i wsp.
Wydane: (2011)

Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.
od: Armitage, J, i wsp.
Wydane: (2009)

Environmental and genetic risk factors for myopathy in Chinese participants from HPS2-THRIVE
od: Hopewell, J, i wsp.
Wydane: (2012)

Clinical trials of lipid-modifying agents: design considerations
od: Bowman, L, i wsp.
Wydane: (2011)

Aspirin for primary prevention of vascular disease in people with diabetes.
od: Haynes, R, i wsp.
Wydane: (2009)

Facilitating participation in clinical trials during pregnancy
od: Vousden, N, i wsp.
Wydane: (2023)

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
od: Armitage, J, i wsp.
Wydane: (2010)

Effects of extended release niacin/laropiprant in 25,673 high-risk individuals receiving statin-based therapy: the HPS2-THRIVE randomized placebo-controlled trial
od: Landray, M, i wsp.
Wydane: (2014)

Effects of extended-release niacin with laropiprant in high-risk patients.
od: Landray, M, i wsp.
Wydane: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
od: Haynes, R, i wsp.
Wydane: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
od: Haynes, R, i wsp.
Wydane: (2014)

N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study
od: Emberson, J, i wsp.
Wydane: (2005)

Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
od: Emily L. Sammons, i wsp.
Wydane: (2024-11-01)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
od: Sarah Parish, i wsp.
Wydane: (2023-03-01)

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
od: Armitage, J, i wsp.
Wydane: (2010)

Deflectometry based calibration of a deformable mirror for aberration correction and remote focusing in microscopy
od: Temma, K, i wsp.
Wydane: (2023)

SenAOReFoc: a closed-loop sensorbased adaptive optics and remote focusing control software
od: Cui, J, i wsp.
Wydane: (2022)

Online Recruitment of Qualitative Study Participants: Lessons Online Recruitment of Qualitative Study Participants: Lessons Learned
od: Erika L. Thompson, i wsp.
Wydane: (2024-09-01)